Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Gains from Sales and Divestitures: 2018-2024

Historic Gains from Sales and Divestitures for Verastem (VSTM) over the last 6 years, with Dec 2024 value amounting to $468,581.

  • Verastem's Gains from Sales and Divestitures rose 716.20% to $642,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $642,000, marking a year-over-year increase of 716.20%. This contributed to the annual value of $468,581 for FY2024, which is N/A change from last year.
  • Latest data reveals that Verastem reported Gains from Sales and Divestitures of $468,581 as of FY2024, which was down 91.16% from $5.3 million recorded in FY2022.
  • Over the past 5 years, Verastem's Gains from Sales and Divestitures peaked at $5.3 million during FY2022, and registered a low of $468,581 during FY2024.
  • For the 2-year period, Verastem's Gains from Sales and Divestitures averaged around $2.9 million, with its median value being $2.9 million (2022).
  • Data for Verastem's Gains from Sales and Divestitures shows a peak YoY skyrocketed of 234.45% (in 2020) over the last 5 years.
  • Yearly analysis of 4 years shows Verastem's Gains from Sales and Divestitures stood at $2.8 million in 2020, then soared by 76.63% to $5.0 million in 2021, then rose by 5.44% to $5.3 million in 2022, then reached $468,581 in 2024.